MEDICAMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICAMA
Largest movements
- Cash +€66,416
up €66,416 (+47.8%), from €138,814 to €205,230
mainly Net result for the year (+€51,525) and Depreciation (+€10,136)
- Tangible fixed assets -€7,478
down €7,478 (-29.0%), from €25,765 to €18,286
of which Furniture and vehicles: -€5,638
- Deferred charges and accrued income -€5,213
down €5,213 (-30.1%), from €17,336 to €12,124
- Reserves +€51,525
up €51,525 (+15.2%), from €338,729 to €390,254
- Gross operating margin -€7,020
down €7,020 (-8.0%), from €87,659 to €80,639
- Financial income +€3,797
up €3,797 (+90.4%), from €4,203 to €8,000
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €381,915 | €435,640 | +€53,725 | +14.1% |
| Fixed assets | 21/28 | €25,765 | €18,286 | -€7,478 | -29.0% |
| Tangible fixed assets | 22/27 | €25,765 | €18,286 | -€7,478 | -29.0% |
| Land and buildings | 22 | €8,130 | €6,622 | -€1,509 | -18.6% |
| Furniture and vehicles | 24 | €15,092 | €9,454 | -€5,638 | -37.4% |
| Other tangible fixed assets | 26 | €2,542 | €2,210 | -€332 | -13.1% |
| Current assets | 29/58 | €356,150 | €417,354 | +€61,204 | +17.2% |
| Current investments | 50/53 | €200,000 | €200,000 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €138,814 | €205,230 | +€66,416 | +47.8% |
| Deferred charges and accrued income | 490/1 | €17,336 | €12,124 | -€5,213 | -30.1% |
| Total equity and liabilities | 10/49 | €381,915 | €435,640 | +€53,725 | +14.1% |
| Equity | 10/15 | €368,410 | €419,103 | +€50,692 | +13.8% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €338,729 | €390,254 | +€51,525 | +15.2% |
| Distributable reserves | 133 | €338,729 | €390,254 | +€51,525 | +15.2% |
| Profit (loss) carried forward | 14 | €17,281 | €16,448 | -€833 | -4.8% |
| Amounts payable | 17/49 | €13,504 | €16,537 | +€3,033 | +22.5% |
| Amounts payable within one year | 42/48 | €13,504 | €16,537 | +€3,033 | +22.5% |
| Trade debts | 44 | €711 | €820 | +€109 | +15.4% |
| Suppliers | 440/4 | €711 | €820 | +€109 | +15.4% |
| Taxes, remuneration and social security | 45 | €7,374 | €6,224 | -€1,150 | -15.6% |
| Taxes | 450/3 | €7,374 | €6,224 | -€1,150 | -15.6% |
| Other amounts payable | 47/48 | €5,419 | €9,493 | +€4,074 | +75.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,328 | €10,136 | -€191 | -1.9% |
| Other operating charges | 640/8 | €1,387 | €705 | -€682 | -49.2% |
| Gross operating margin | 9900 | €87,659 | €80,639 | -€7,020 | -8.0% |
| Operating profit (loss) | 9901 | €75,944 | €69,797 | -€6,146 | -8.1% |
| Financial income | 75/76B | €4,203 | €8,000 | +€3,797 | +90.4% |
| Recurring financial income | 75 | €4,203 | €8,000 | +€3,797 | +90.4% |
| Financial charges | 65/66B | €49 | €48 | -€1 | -2.5% |
| Recurring financial charges | 65 | €49 | €48 | -€1 | -2.5% |
| Profit (loss) for the period before taxes | 9903 | €80,097 | €77,749 | -€2,348 | -2.9% |
| Income taxes | 67/77 | €26,874 | €26,224 | -€650 | -2.4% |
| Profit (loss) for the period | 9904 | €53,223 | €51,525 | -€1,697 | -3.2% |
| Profit (loss) for the period to be appropriated | 9905 | €53,223 | €51,525 | -€1,697 | -3.2% |
Source: filed annual accounts (NBB), financial years ended 31 October 2024 and 31 October 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.